Se Jin Oh
Korea University(KR)Samsung Medical Center(KR)Korea University(JP)
Publications by Year
Research Areas
Genomics, phytochemicals, and oxidative stress, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Genetics, Aging, and Longevity in Model Organisms, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors(2020)94 cited
- → Engineered Human Ferritin Nanoparticles for Direct Delivery of Tumor Antigens to Lymph Node and Cancer Immunotherapy(2016)93 cited
- → HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells(2017)86 cited
- → A PEGylated hyaluronic acid conjugate for targeted cancer immunotherapy(2017)51 cited
- → LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells(2020)51 cited
- → Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3–NANOG Axis(2018)50 cited
- → TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway(2023)46 cited
- → PD-L1 siRNA–hyaluronic acid conjugate for dual-targeted cancer immunotherapy(2022)44 cited
- → Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance(2018)44 cited
- → Regulation of mRNA export through API5 and nuclear FGF2 interaction(2020)39 cited